{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Added in vitro to rat cortical membrane preparation , abecarnil increased [ 3H ] GABA binding , enhanced muscimol - stimulated 36Cl - uptake and reduced the binding of t - [ 35S ] butylbicyclophosphorothionate ( [ 35S ] TBPS ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None identified in the given paragraph |\n\nThe paragraph is about the effects of abecarnil on rat cortical membrane preparation, specifically its impact on [3H] GABA binding, muscimol-stimulated 36Cl uptake, and TBPS binding. It does not mention any diseases."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None identified in the given paragraph |\n\nThe paragraph describes the effects of abecarnil on rat cortical membrane preparation, which includes changes in [3H] GABA binding, muscimol-stimulated 36Cl uptake, and TBPS binding. These are not diseases."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Added in vitro to rat cortical membrane preparation , abecarnil increased [ 3H ] GABA binding , enhanced muscimol - stimulated 36Cl - uptake and reduced the binding of t - [ 35S ] butylbicyclophosphorothionate ( [ 35S ] TBPS ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| [3H] GABA |\n| rat cortical membrane preparation |\n| abecarnil |\n| muscimol |\n| [36Cl] |\n| t-[35S] butylbicyclophosphorothionate ([35S] TBPS) |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| [3H] GABA |\n| abecarnil |\n| [36Cl] |\n| t-[35S] butylbicyclophosphorothionate ([35S] TBPS) |\n\nNote: \"rat cortical membrane preparation\" is not a clear chemical entity as it refers to a biological preparation."}
  ]
}